Accumulating evidence has highlighted the emergence of STING signaling as an attractive focal point in cancer therapeutics (Chen et al., 2020; Corrales et al., 2015; Kulasinghe et al., 2021; Shen et al., 2022; Zhang et al., 2022). The gene discussed is STING1; the disease is cancer.